IDB 1056

Drug Profile

IDB 1056

Alternative Names: Delphinidin chloride

Latest Information Update: 22 Aug 2007

Price : $50

At a glance

  • Originator Inverni della Beffa
  • Developer Indena; Inverni della Beffa
  • Class Antihyperglycaemics; Small molecules; Vascular disorder therapies; Vasodilators
  • Mechanism of Action Cell membrane permeability inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Diabetic angiopathies; Varicose veins; Venous insufficiency

Most Recent Events

  • 31 Aug 1999 No-Development-Reported for Varicose veins in Italy (Unknown route)
  • 31 Aug 1999 No-Development-Reported for Venous insufficiency in Italy (Unknown route)
  • 14 Jul 1998 No-Development-Reported for Diabetic angiopathies in Italy (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top